4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-25-006919
CHIEF COMMERCIAL OFFICER sold 4,869 shares at an average $32.67 ($159,090)
- CHIEF COMMERCIAL OFFICER acquired 4,869 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-03-03 | Option exercise 10b5-1 | +4,869 | $8.22 | $40,023 | 4,869 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-03-03 | Sale 10b5-1 | −4,369 | $32.61 | $142,474 | 500 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-03-03 | Sale 10b5-1 | −500 | $33.23 | $16,615 | 0 | D |
| Derivatives | |||||||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-03-03 | Option exercise · Stock Option 10b5-1 | −4,869 | 0 | D | ||
| Open-market sales · 4,869 sh · avg $32.67 · $159,090 | |||||||
Loading xslF345X05/form4-03052025_040301.xml…